IRIS
Lanzafame, Massimiliano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.527
AS - Asia 1.361
EU - Europa 662
SA - Sud America 330
AF - Africa 58
OC - Oceania 16
Totale 3.954
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.458
SG - Singapore 435
IT - Italia 293
VN - Vietnam 284
BR - Brasile 260
CN - Cina 257
KR - Corea 166
FR - Francia 70
DE - Germania 65
NL - Olanda 58
FI - Finlandia 44
IN - India 42
GB - Regno Unito 38
HK - Hong Kong 35
CA - Canada 30
MX - Messico 27
ZA - Sudafrica 27
AR - Argentina 22
PK - Pakistan 20
IQ - Iraq 19
LV - Lettonia 17
BD - Bangladesh 16
EC - Ecuador 15
TR - Turchia 15
JP - Giappone 14
PL - Polonia 14
AU - Australia 13
ID - Indonesia 13
RU - Federazione Russa 12
MA - Marocco 11
IE - Irlanda 9
AT - Austria 7
CO - Colombia 7
ES - Italia 7
PE - Perù 7
SE - Svezia 7
UA - Ucraina 7
VE - Venezuela 7
JO - Giordania 6
PH - Filippine 6
SA - Arabia Saudita 6
EG - Egitto 5
PY - Paraguay 5
MY - Malesia 4
UY - Uruguay 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
KE - Kenya 3
NZ - Nuova Zelanda 3
TT - Trinidad e Tobago 3
BF - Burkina Faso 2
CH - Svizzera 2
CL - Cile 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IL - Israele 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
SI - Slovenia 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
BE - Belgio 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
ML - Mali 1
MN - Mongolia 1
MW - Malawi 1
NG - Nigeria 1
PA - Panama 1
QA - Qatar 1
SN - Senegal 1
ST - Sao Tome e Principe 1
SV - El Salvador 1
TW - Taiwan 1
Totale 3.954
Salva come PNG Salva come JPEG
Città #
Dallas 303
San Jose 261
Singapore 256
Ashburn 170
Seoul 165
Ho Chi Minh City 93
Council Bluffs 74
Los Angeles 68
Trento 64
Hanoi 58
Chicago 52
Beijing 44
Lauterbourg 43
Amsterdam 40
Helsinki 37
Munich 35
Hong Kong 32
New York 30
São Paulo 30
Orem 27
Rome 26
Salt Lake City 24
Buffalo 21
Johannesburg 21
Denver 19
St Louis 19
Cavalese 17
Da Nang 17
Riga 17
Santa Clara 15
Cornedo Vicentino 14
Jinan 14
Mexico City 14
Redondo Beach 13
Atlanta 12
Haiphong 12
Marcianise 12
Milan 12
Tokyo 12
Warsaw 12
Karachi 11
Naples 11
Chennai 10
London 10
Phoenix 10
Elk Grove Village 9
Guangzhou 9
Houston 9
Manchester 9
Montreal 9
Tampa 9
Terrasini 9
Verona 9
Clifton 8
Frankfurt am Main 8
Ankara 7
Baghdad 7
Mumbai 7
Padua 7
Rio de Janeiro 7
Boardman 6
Brooklyn 6
Dublin 6
North Bergen 6
Ziano di Fiemme 6
Belo Horizonte 5
Brasília 5
Cairo 5
Canoas 5
Hải Dương 5
Istanbul 5
Lahore 5
Lancaster 5
Nuremberg 5
Salvador 5
Seattle 5
Shanghai 5
Stockholm 5
Toronto 5
Wilmington 5
Amman 4
Boston 4
Can Tho 4
City of London 4
Curitiba 4
Dhaka 4
Falkenstein 4
Hefei 4
Hillsboro 4
Kansas City 4
Miami 4
Newark 4
Poplar 4
Querétaro 4
Roverbella 4
San Francisco 4
Sydney 4
Tashkent 4
Thái Bình 4
Turin 4
Totale 2.565
Salva come PNG Salva come JPEG
Nome #
Antibiotic Resistance Patterns Among Uropathogens in Female Outpatients Affected by Uncomplicated Cystitis: Focus on Fosfomycin Trometamol 141
A Precision Medicine Model for Targeted Antibiotic Therapy in Urinary Tract Infections: A Valuable Tool to Reduce Hospitalization Stay and the Time to Switch to Oral Treatment 130
Meningite da Escherichia Coli in una persona con infezione da HIV; descrizione di un caso clinico e revisione della letteratura = Escherichia Coli meningitis in a person living with HIV infection: a clinical case and review of the literature. 103
Advances in HIV Treatment: Long-Acting Antiretrovirals and the Path Toward a Cure 99
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 89
'High' antiretroviral deintensification strategy and cellular HIV DNA levels 86
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 83
Uso degli antibiotici nel fine vita 82
Breastfeeding in women living with HIV in high-income countries: It's time to act 81
Prospective analysis of febrile neutropenia patients with bacteraemia: the results of an international ID-IRI study 73
Bridging the gap in bloodstream infection management: a survey among non-infectious disease physicians 72
Mini-review: Silico-tuberculosis 72
A multicentre real-life prospective cohort study on effectiveness, durability and safety of long-acting injectable cabotegravir and rilpivirine in northern Italy: the LONGITUDE study 71
When an underestimated zoonosis and antimicrobial resistance collide: Corynebacterium ulcerans 71
Benign acute viral myositis in African migrants: a clinical, serological and pathological study 67
Primary cutaneous cryptococcosis in a HIV infested patient: case report 65
Treatment of Candida glabrata native valve endocarditis with rezafungin: a case report 64
Recurrent UTI: Questions and Answers on Clinical Practice 64
Emerging strategies in tackling antimicrobial resistance in urology: Narrative review and expert opinion 61
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study 58
Acceptability of Switching to Long-Acting Cabotegravir and Rilpivirine Among People Living with HIV on Dolutegravir/Rilpivirine Combination: A Single-Center Experience 57
HIV screening of migrants in the autonomous Province of Trento (North-Eastern Italy) 57
High malaria parasitemia in an Italian man and severe delayed hemolytic anemia 56
The diagnostic yield of the Meares & Stamey test can be significantly improved by symptom-based patient selection and the experience of the test performer 55
Profiles of primary brain abscesses and their impact on survival: An international ID-IRI study 54
Rezafungin Utilisation in Real Life—FungiScope Results From Europe and the United States 53
Is monoclonal antibody administration necessary in all vaccinated patients with breakthrough COVID-19 infections? 53
Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression: a prospective cohort study 52
"High" antiretroviral deintensification, a strategy to avoid drug interactions and unfavourable long-term effects of HAART 50
Klebsiella pneumoniae resistant to carbapenems: bloodstream infection prevalence before and during the SARS-CoV-2 pandemic in a tertiary level, North-Eastern Italian Hospital 48
WISE (Web-based Infectious Support for the Elderly) Initiative: Improving Infectious Disease Management in LTCFs―Experience From Northern Italy 47
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study 44
Adherence to HAART in HIV 43
Relationship between vertebral fractures, bone mineral density, and osteometabolic profile in HIV and Hepatitis B and C-infected patients treated with ART 42
Behavioural and demographic correlates of undiagnosed HIV infection in a MSM sample recruited in 13 European cities 42
Acute mediastinitis: a severe complication of transdermal therapy in a patient with ischaemic heart disease. A case report 41
A reduced dose of darunavir/ritonavir is effective in PI-experienced HIV-infected patients 41
Short-cycle therapy (5 days on/2 days off) with a lamivudine + dolutegravir regimen in a cohort of virologically suppressed patients with HIV infection 40
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report 40
Classical fever of unknown origin in 21 countries with different economic development: an international ID-IRI study 39
A Maintenance Dose of Atazanavir/Ritonavir 200/100 mg Once Daily Is Effective in Virologically Suppressed HIV-1–Infected Patients 38
“Terapia intermittente” con bictegravir/emtricitabina/tenofovir alafenamide in una piccola coorte di pazienti con infezione da HIV, virologicamente soppressi = Short cycle therapy with bictegravir/emtricitabine/tenofovir alafenamide in a small cohort of virally suppressed people living with HIV. 38
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor 37
Rapid radiological improvement of COVID-19 pneumonia after treatment with tocilizumab 37
Computational characterization of peptide binding stability to HLA-C allotypes and its association with HIV-1 infection progression and HIV-1 related neurocognitive impairment. 36
. Raltegravir plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-positive Patients: Safety, Efficacy and Pharmacokinetics 36
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 36
Short-Cycle Therapy with Bictegravir/Emtricitabine/Tenofovir Alafenamide in a Small Cohort of Virally Suppressed People Living with HIV: A Long-Term Follow-Up 34
Aetiology of pneumonia following isolated closed head iniury 33
Antiretroviral therapy in low-resource settings 33
Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients 33
Simplification to dual-therapy containing lamivudine and darunavir/ritonavir or atazanavir/ritonavir in HIV-infected patients on virologically suppressive antiretroviral therapy 32
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation 30
HIV treatment default in sub-Saharan Africa: issues and possible solutions 29
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona) 28
The burden and epidemiology of community-acquired central nervous system infections: a multinational study 28
Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients 27
Antiretroviral therapy-associated diseases are common in the long-term 27
Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up 27
HIV-1-associated neurocognitive disorders: is HLA-C binding stability to β2-microglobulin a missing piece of the pathogenetic puzzle? 27
HIV and SARS-Coronavirus-2 Epidemics: Possible Interactions and Need for Studies, Especially in Africa 27
Letter to the Editor: Dolutegravir Monotherapy and Body Weight Gain in Antiretroviral Naïve Patients 27
Cardiovascular Drug Interactions with Nirmatrelvir/Ritonavir for COVID-19: Considerations for Daily Practice. 24
Features of Mpox infection: The analysis of the data submitted to the ID-IRI network 24
HIV-1 RNA levels in semen of people on 'short-cycle' antiretroviral therapy 23
Patient-centered Care and Treatment in HIV Infection 23
Influenza dell’attività fisica sul valore ematico dei lipidi in una piccola coorte di pazienti che vivono con infezione da HIV, soppressi e dislipidemici, dopo lo switch da un regime contenente tenofovir alafenamide a dolutegravir/rilpivirina = Influence of physical activity level on serum lipid values in a small cohort of suppressed dyslipidemic people living with HIV after switching from a tenofovir alafenamide regimen to dolutegravir/rilpivirine. 23
HIV serostatus knowledge and serostatus disclosure with the most recent anal intercourse partner in a European MSM sample recruited in 13 cities: results from the Sialon-II study 23
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients 22
Successful Antifungal Combination Therapy and Surgical Approach for Aspergillus fumigatus Suppurative Thyroiditis Associated with Thyrotoxicosis and Review of Published Reports 22
Short-cycle therapy in {HIV}-infected adults: rilpivirine combination 4 days on/3 days off therapy 22
Short Cycle, Intermittent Therapy: A Valuable Option in Selected, Virologically Suppressed People Living with HIV 21
Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials 21
Disseminated Mycobacterium chimaera infection after open heart surgery in an Italian woman: a case report and a review of the literature 20
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir 20
The treatment of latent TB infection in HIV-positive people: the Verona experience 20
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient 20
Successful Treatment of Castleman's Disease with HAART in two HIV-infected patients. 18
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life 18
Socio-demographic Characteristics, Sexual and Test-Seeking Behaviours Amongst Men Who have Sex with Both Men and Women: Results from a Bio-behavioural Survey in 13 European Cities 17
Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study) 17
DRIVE-AHEAD Trial's Results and the Need for a More Appropriate Comparator Drug 16
Dolutegravir monotherapy: an option for highly adherent HIV1-infected naive patients with relatively low zenith HIV-RNA? 16
Mycobacterium chimaera infections following cardiac surgery in Italy: results from a National Survey Endorsed by the Italian Society of Cardiac Surgery 16
Dolutegravir Monotherapy's Virological Efficacy in a Highly Treatment-Experienced Patient 16
Optimal fosamprenavir regimen to prevent lipid abnormalities. 15
Efavirenz dose reduction in HIV-infected patients 15
Voluntary or Universal HIV testing in Italy? 14
Cutaneous abscess due to Eubacterium lentum in injection drug user: a case report and review of the literature 14
HIV infection should no longer be detected at late stages in Italy 14
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings 14
Hyperacute unilateral gonococcal endophtalmitis in an HIV-infected man without genital infection 13
Hypersensitivity syndrome (DRESS) and meningoencephalitis associated with nevirapine therapy 13
Tenofovir coadministration is not associated with lower unboosted atazanavir plasma exposure in the clinical setting 13
Quantitative Trait Loci for CD4:CD8 Lymphocyte Ratio Are Associated with Risk of Type 1 Diabetes and HIV-1 Immune Control 13
Delayed CD4 cell recovery in HIV-associated disseminated non-tuberculous mycobacterial disease 12
Chagas disease in Italy: breaking an epidemiological silence 12
Can antiretroviral therapy be safely interrupted and, if so, when? 11
Sindrome lipodistrofica in un paziente con infezione da hiv,trattato con pentoxifillina 11
Long -term efficacy of dual nucleoside transcriptase inhibitor antiretroviral therapy in HIV-1 infection 10
Totale 3.942
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.349
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025303 0 0 0 0 0 0 0 0 1 180 34 88
2025/20263.975 113 157 587 599 621 274 322 221 517 564 0 0
Totale 4.278